Summary
The product MESTER, manufactured by Driada Medical, underwent laboratory testing to assess its composition and quality. The sample, identified by batch number 023805, was analyzed by Janoshik Analytical. The analysis confirmed the presence of mesterolone, with a measured amount of 26.49 mg per pill, which is slightly above its typical specification of 25 mg. This result indicates a 5.96% variance, demonstrating accurate dosage as per the expected standards.
The testing process was initiated on 25 March 2022, with the sample received on 29 March 2022, and the analysis completed on 31 March 2022. The sample was submitted and funded by Driada Medical, requiring careful scrutiny due to potential conflicts of interest. Notably, the sample was retested twice to ensure result reliability. This report is published to support educational and harm reduction purposes, allowing users to make informed decisions regarding anabolic steroid products.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: MESTER
- Active Ingredient: Mesterolone
- Batch Number: 023805
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #19555
- Testing Ordered: 25 March 2022
- Sample Received: 29 March 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 25 mg per pill (as typical for this product type)
- Measured Dosage: 26.49 mg per pill
- Accuracy: 105.96% (5.96% above the expected specification)
Verification Details
- Verification URL: https://janoshik.com/tests/19555_G1YKABUTXZ5R
- Originally Published: https://thinksteroids.com/community/posts/2933555/
Evaluation of Manufacturer-Funded Testing
Since the test was both submitted and funded by the manufacturer, Driada Medical, it is important to approach the findings with careful consideration. Factors such as potential biases and selective sample submissions have been evaluated. The credibility of Janoshik Analytical, known for its transparent practices and reliable results, adds confidence to the findings. However, additional independent testing would further strengthen consumer confidence in the product’s quality.
Conclusion
This analysis underscores the significance of third-party laboratory testing in ensuring the quality and accuracy of anabolic steroid products. The test results for MESTER indicate that the product meets its expected dosage requirements, with minimal variance. Publishing such reports serves as a valuable resource for harm reduction and consumer education in the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside independent results. Readers are encouraged to interpret this information responsibly.